This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, To Advisory Board

JOHNSTOWN, Pa., Jan. 29 /PRNewswire-FirstCall/ -- EP Global Communications, Inc. (EPGL), (the Company), (Pink Sheets: EPGL), ( www.eparent.com), the parent company of Exceptional Parent ( EP) magazine, is proud to announce that Stephen L. DeFelice, MD, has joined the EPGL Advisory Board. Dr. DeFelice is one of the world's leading authorities on nutraceutical products and is credited for introducing the term "nutraceutical." 

"This addition to our team of experts will enable EPGL to more authoritatively evaluate and provide accurate and scientifically sound information about the multitude of products offered in the vast arena of nutraceuticals and indeed unique medical devices," stated the Company's President and CEO, Joseph M. Valenzano, Jr.  "EP Global Communications intends to use its multitude of relationships in the healthcare, pharmaceutical, and biotech industries and its impeccable reputation for science-based, credible information to objectively review those products which can have a positive effect on the lives of people with disabilities and special healthcare needs and their families and caregivers."  

Stephen L. DeFelice, MD is the Founder and Chairman of the Foundation for Innovation in Medicine (FIM), a nonprofit organization established in 1976 with the purpose of accelerating medical discovery by establishing a more productive clinical research community.  A graduate of Temple University, Dr. DeFelice received his MD from Jefferson Medical College in Philadelphia. He was a National Institute of Health (NIH) fellow in endocrinology, diabetes, and metabolic disease at Jefferson and a fellow in clinical pharmacology at St. Vincent's Hospital and Medical Center in New York City. Dr. DeFelice is the former Chief of Clinical Pharmacology at the Walter Reed Army Institute of Research (WRAIR). His 35-year experience with carnitine, a naturally occurring substance with multiple medical benefits, sparked his interest and determination to encourage medical discovery. His experience taught him that the promise of medical technology is exploding, but the barriers, costs, and risks of clinically testing their promise, a critical step in medical discovery, are also exploding.

In 1972, Dr. DeFelice wrote the book Drug Discovery: The Pending Crisis (Medcom Press) to alert the US to the fact that medical discovery was and would continue to be significantly delayed because of the formidable barriers to conducting clinical research. He first proposed the idea of physician volunteers or "doctornauts" (a term he coined) who would be more free than others to volunteer for clinical research. This simple act would lead to the clinical testing of more potential medical discoveries.

Today, FIM is involved in two initiatives: the Nutraceutical Research and Education Act (NREA) and the need for Congress to enact the Doctornaut Act. Senator Bill Frist (R-TN) has expressed a strong interest in the latter concept.

About EP Global Communications, Inc.

EP Global Communications, Inc., parent company of Exceptional Parent ( EP) magazine, is a 39-year-old, award-winning, multi-media publishing and communications company, providing timely and indispensable resources and information to families and professionals caring for the needs of children and adults with disabilities and special health care needs, including families in the U.S. Military.

Safe Harbor Statement

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

SOURCE EP Global Communications, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,155.57 +124.43 0.73%
S&P 500 2,000.95 +16.82 0.85%
NASDAQ 4,550.29 +31.3880 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs